Optimization of experimental parameters for the production of LMWH-loaded polymeric microspheres

Drug Design, Development and Therapy

Volumn , Issue 2, 2008, Pages 39-47

  Motlekar, Nusrat ^a   Youan, Bi Botti ^a  

^a BUTLER UNIVERSITY   (United States)

Author keywords

DOE; Fractal; LMWH; Microspheres; Spray drying

Indexed keywords

EUDRAGIT; LOW MOLECULAR WEIGHT HEPARIN; MICROSPHERE; POLYMER;

ARTICLE; DRUG DESIGN; DRUG FORMULATION; ELECTRON MICROSCOPY; FLOW RATE; FRACTAL ANALYSIS; MOISTURE; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING;

EID: 77953662360     PISSN: None     EISSN: 11778881     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Avnir D, Pfeifer P. 1983. Chemistry in noninteger dimensions between two and three. II. Fractal surfaces of adsorbents. J Chem Phys, 79:3566-3573
2. Bittner B, Ronneberger B, Zange R, et al. 1998. Bovine serum albumin loaded poly(lactide-co-glycolide) microspheres: the influence of polymer purity on particle characteristics. J Microencapsul, 15:495-514.
3. Bjornsson TD, Schneider DE, Hecht AR. 1988. Effects of N-deacetylation and N-desulfation of heparin on its anticoagulant activity and in vivo disposition. J Pharmacol Exp Ther, 245:804-808
4. Bodmeier R, Chen HG. 1988. Preparation of biodegradable poly(+/-)lactide microparticles using a spray-drying technique. J Pharm Pharmacol, 40:754-757
5. Box GBD. 1960. Some new three level designs for the study of quantitative variables. Technometrics, 2:455-475
6. Breddin HK, Hach-Wunderle V, Nakov R, ET AL. 2001. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis. N Engl J Med, 344:626-631
7. Broadhead ER. 1992. The spray drying of pharmaceuticals. Drug Dev and Ind Pharm, 18:1169-1206
8. Clark N. 1986. Powder Technology. 46:45-52.
9. Conti B, Pavanetto F, Genta I. 1992. Use of polylactic acid for the preparation of microparticulate drug delivery systems. J Microencapsul, 9:153-166
10. Davies SH. 1999. Statistical methodology. Journal of the Royal Statistical Society (series B), 61:3-
11. Esposito E, Roncarati R, Cortesi R, et al. 2000. Production of Eudragit microparticles by spray-drying technique: influence of experimental parameters on morphological and dimensional characteristics. Pharm Dev Technol, 5:267-278
12. Farin D, Avnir D. 1992. Use of fractal geometry to determine effects of surface morphology on drug dissolution. J Pharm Sci, 81:54-57
13. Friel JJ, Pande CS. 1998. A direct determination of fractal dimension of fracture surfaces using scanning electron mocroscopy and stereoscopy. J Mater Res, 8:100-106
14. Gallus AS. 1990. Anticoagulants in the prevention of venous thromboembolism. Baillieres Clin Haematol, 3:651-684
15. Grau E, Tenias JM, Real E, et al. 2001. Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism. Am J Hematol, 67:10-14.
16. Jiao YY, Ubrich N, Hoffart V, et al. 2002. Preparation and characterization of heparin-loaded polymeric microparticles. Drug Dev Ind Pharm, 28:1033-1041
17. Kondo N, Iwao T, Masuda H, et al. 1993. Improved oral absorption of a poorly water-soluble drug, HO-221, by wet-bead milling producing particles in submicron region. Chem Pharm Bull, (Tokyo). 41:737-740 (Pubitemid 23166149)
18. Larsen AK, Rice KG, Linhardt RJ, et al. 1989. Resistance of heparinase-derived heparin fragments to biotransformation. J Biol Chem, 264:1570-1577
19. Mandelbrot B. 1982. The fractal geometry of nature. San Francisco: Freeman.
20. Masters K. 1990. Spray Drying Handbook. New York: Longmans.
21. Money SR, York JW. 2001. Development of oral heparin therapy for prophylaxis and treatment of deep venous thrombosis. Cardiovasc Surg, 9:211-218 (Pubitemid 32381068)
22. Pfeifer P, Avnir D. 1983. Chemistry in noninteger dimensions between two and three. I. Fractal theory of heterogenous surfaces. J Chem Phys, 79:3558-3565
23. Ross BP, Toth I. 2005. Gastrointestinal absorption of heparin by lipidization or coadministration with penetration enhancers. Current Drug Delivery, 2:277-287 (Pubitemid 40944000)
24. Salartash K, Gonze MD, Leone-Bay A, et al. 1999. Oral low-molecular weight heparin and delivery agent prevents jugular venous thrombosis in the rat. J Vasc Surg, 30:526-531 (Pubitemid 29441794)
25. Tattini V, Parra DF, Polakiewicz B, et al. 2005. Effect of lyophilization on the structure and phase changes of PEGylated-bovine serum albumin. Int J Pharm, 304:124-134 (Pubitemid 41427656)
26. Torrado J, Illum L, Davis S. 1989. Particle size and size distribution of albumin microspheres produced by heat and chemical stabilization. Int J Pharm, 51:85-93. (Pubitemid 19087837)
27. U.S. Pharmacopoeia National Formulary, USP XXIII NF XVIII. 1994. pg. 2300.
28. Wan L, Heng P, Chia C. 1991. Preparation of coated particles using a spray drying process with an aqueous system. Int J Pharm, 77:183-191
29. Weltermann A, Kyrle PA, Eichinger S. 2003. Novel anticoagulants for the prevention and treatment of venous thromboembolism. Wien Med Wochenschr, 153:426-433 (Pubitemid 37368907)